Longitudinal Monitoring of Energy Expenditure, Dynamic Stability and Fatigue During Gait in Patients With Cerebellar Ataxia Gene

NCT02903290 | Completed

• 1 other identifier: 15-AOI-10
• Study Type: interventional
• Target: 15
• Locations: 1 country
• Sites: 1

Brief Summary

Genetic cerebellar ataxias involves progressive degeneration of the cerebellum. Their overall prevalence is estimated at 2-4 cases per 100 000 people. These diseases are manifested by a static and kinetic cerebellar syndrome characterized by impaired balance, coordination, and an ataxic gait. To date, no therapy is available for patients and physical therapy is essential and recommended. The evolution of the pathology causes a degradation of walking, increased instability and risk of falling. In one year, between 74% and 93% of patients reported having fallen at least once. Falls prevention by understanding the mechanisms affecting stability is a major issue in the management of these patients physiotherapy. The analysis of the literature, we assume that there exists a trio "fatigue - instability - energy expenditure" in which the three parameters would influence each other. To date, we do not have data to characterize these interrelationships and their evolution over time. STUDY OBJECTIVES: The main objective is to study the relationship between changes in energy expenditure and changes in instability when walking at one year in patients with cerebellar ataxia gene. The secondary objectives are to study, after one year of development, the relationship between fatigue, instability, energy consumption, the number of falls, the severity of ataxia and quality of life. CONDUCT OF THE STUDY: This is a pilot, multicenter, interventional. The projected duration of patient recruitment will be 12 months and the total number of patients will be included in 15. The duration of participation in this study is 12 months for each patient. The anticipated duration of the study is 30 months. Development of the study: Patients included will perform two sets (S1 and S2) tests a year apart including the evaluation of ataxia according Scale for the assessment and rating of ataxia (SARA); measuring the quality of life through SF36 (The Short Form (36)) Questionnaire; quantifying the severity of fatigue perceived by FSS questionnaire quantifying the severity of physical tiredness by VAS before and after physical activity; quantified analysis of walking on walking track GAITRite® (with score calculation FAP and GVI) before and after physical activity; physical activity like walking on a treadmill (with measurement of maximal voluntary quadriceps by manual dynamometer before and after physical activity to ensure the induction of fatigue). Patients will be provided with a portable device for analyzing gas exchange FitMateMED® (COSMED, Rome, Italy) during walking analyzes GAITRite®.

Conditions

Cerebellar Ataxia

Outcome Measures

Primary Outcomes (3)

• Pre physical activity scores (Gilette Gait Index (GVI)) to pre exercise walking

  The main objective is to investigate the relationship between changes in energy expenditure and changes in instability when walking at one year in patients with cerebellar ataxia gene.

  At one year

• Oxygen consumption to pre exercise walking

  The main objective is to investigate the relationship between changes in energy expenditure and changes in instability when walking at one year in patients with cerebellar ataxia gene.

  At one year

• Pre physical activity scores (Functional Ambulation Performance Score (FAPS)) to pre exercise walking

  The main objective is to investigate the relationship between changes in energy expenditure and changes in instability when walking at one year in patients with cerebellar ataxia gene.

  At one year

Secondary Outcomes (2)

• Functional Systems Scores (FSS) score

  At one year

• Visual Analog Scale (VAS) tiredness

  At one year

Study Arms (1)

cerebellar ataxia

OTHER

Evaluation ataxia according SARAs; measuring the quality of life through SF36 Questionnaire; quantifying the severity of fatigue perceived by FSS questionnaire quantifying the severity of physical tiredness by VAS before and after physical activity; quantified analysis of walking on walking track GAITRite® (with score calculation FAP and GVI) before and after physical activity; physical activity like walking on a treadmill (with measurement of maximal voluntary quadriceps by manual dynamometer before and after physical activity to ensure the induction of fatigue). Patients will be provided with a portable device for analyzing gas exchange FitMateMED® (COSMED, Rome, Italy) during walking analyzes GAITRite®

Other: Longitudinal Monitoring of Energy Expenditure, Dynamic Stability and Fatigue During Gait; Other: walking track GAITRite,manual dynamometer, and treadmill

Interventions

Longitudinal Monitoring of Energy Expenditure, Dynamic Stability and Fatigue During Gait OTHER

Longitudinal Monitoring of Energy Expenditure, Dynamic Stability and Fatigue During Gait

cerebellar ataxia

walking track GAITRite,manual dynamometer, and treadmill OTHER

walking track GAITRite,manual dynamometer, and treadmill

cerebellar ataxia

Eligibility Criteria

• Age: 18 Years - 60 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• Patient aged 18 to 60;
• Patient with cerebellar syndrome genetically determined or evidence of inheritance;
• Patient walking more than 50 meters independently, with or without technical assistance;
• Patient likely to be followed regularly for at least one year;
• Patient has given written informed consent;
• Patient affiliated to Social Security.

You may not qualify if:

• Patient with any other injuries not attributable to the pathology and can influence the running tests according to physician judgment;
• Patient with any disease or condition incompatible to the success of the study according to the doctor's judgment;
• Patient not strolling or sauntering only with a third person to help;
• Major person under guardianship;
• People hospitalized without his consent and not protected by law;
• Nobody deprived of liberty;
• Patients speakers.

Sponsors & Collaborators

• Centre Hospitalier Universitaire de Nice: lead

Study Sites (1)

CHU de Nice

Nice, France

Location

MeSH Terms

Conditions

Cerebellar Ataxia

Condition Hierarchy (Ancestors)

Cerebellar Diseases; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Ataxia; Dyskinesias; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Officials

• SACCONI Sabrina

  Centre Hospitalier Universitaire de Nice

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 22, 2016
• First Posted: September 16, 2016
• Study Start: January 25, 2017
• Primary Completion: January 31, 2023
• Study Completion: January 31, 2023
• Last Updated: March 19, 2025

Record last verified: 2025-03

Locations

FR (1)